This study aimed to determine whether mRNA and protein levels of cartilage oligomeric
matrix protein (COMP), a glycoprotein responsible for modulating homeostasis of …

AIM: To assess serum cartilage oligomeric matrix protein (COMP) as a marker of cirrhosis
and risk of progression to hepatocellular carcinoma (HCC). METHODS: A COMP enzyme …

Serum levels of cartilage oligomeric matrix protein (COMP) has been presented as a
biomarker of liver fibrosis in several cross-sectional studies. COMP is also an essential …

Cartilage oligomeric matrix protein (COMP) interacts with various extracellular matrix
proteins in tissues. Elevated COMP levels recently linked to worse overall survival in …

Background & Aims Liver fibrosis is characterized by significant accumulation of
extracellular matrix (ECM) proteins, mainly fibrillar collagen-I, as a result of persistent liver …

Cartilage oligomeric matrix protein (COMP) is a biomarker of fibrosis in lung and skin. In this
exploratory study we investigated the biomarker potential of COMP in chronic hepatitis C …

Background: Cartilage oligomeric matrix protein (COMP) is the fifth member of the
thrombospondin family of extracellular, calcium‐binding proteins. It was initially isolated and …

Cartilage oligomeric matrix protein (COMP) is an emerging regulator of tumor progression.
The aim of this study was to evaluate the expression of COMP in periampullary …

Background & aims Recently we have shown that cartilage oligomeric matrix protein
(COMP), a fibrillar collagen assembly regulator, is strongly associated with cirrhosis and …

This study aimed to determine whether circulating levels of clusterin (CLU), an extracellular
chaperone implicated in cholestatic and fibrotic processes, are associated with clinical …